These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27092190)

  • 1. Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator.
    Rahmawati A; Chishaki A; Ohkusa T; Sawatari H; Tsuchihashi-Makaya M; Ohtsuka Y; Nakai M; Miyazono M; Hashiguchi N; Sakurada H; Takemoto M; Mukai Y; Inoue S; Sunagawa K; Chishaki H
    J Arrhythm; 2016 Apr; 32(2):102-7. PubMed ID: 27092190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender disparities in quality of life and psychological disturbance in patients with implantable cardioverter-defibrillators.
    Rahmawati A; Chishaki A; Sawatari H; Tsuchihashi-Makaya M; Ohtsuka Y; Nakai M; Miyazono M; Hashiguchi N; Sakurada H; Takemoto M; Mukai Y; Inoue S; Sunagawa K; Chishaki H
    Circ J; 2013; 77(5):1158-65. PubMed ID: 23337265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender disparities in anxiety and quality of life in patients with an implantable cardioverter-defibrillator.
    Habibović M; van den Broek KC; Theuns DA; Jordaens L; Alings M; van der Voort PH; Pedersen SS
    Europace; 2011 Dec; 13(12):1723-30. PubMed ID: 21821854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phantom shocks in implantable cardioverter-defibrillator recipients: impact of education level, anxiety, and depression.
    Varghese S; Geller JC; Ohlow MA
    Herzschrittmacherther Elektrophysiol; 2019 Sep; 30(3):306-312. PubMed ID: 31440897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-morbidity burden, psychological distress, and quality of life in implantable cardioverter defibrillator recipients: Results from a nationwide study.
    Miller JL; Thylén I; Elayi SC; Etaee F; Fleming S; Czarapata MM; Lennie TA; Moser DK
    J Psychosom Res; 2019 May; 120():39-45. PubMed ID: 30929706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients.
    Thylén I; Dekker RL; Jaarsma T; Strömberg A; Moser DK
    J Psychosom Res; 2014 Aug; 77(2):122-7. PubMed ID: 25077853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decision regret in implantable cardioverter-defibrillator recipients : A cross-sectional analysis on patients that regret their decision after ICD implantation.
    Varghese S; Geller JC; Ohlow MA
    Herzschrittmacherther Elektrophysiol; 2020 Mar; 31(1):77-83. PubMed ID: 32078717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in anxiety and concerns about the cardioverter defibrillator.
    Spindler H; Johansen JB; Andersen K; Mortensen P; Pedersen SS
    Pacing Clin Electrophysiol; 2009 May; 32(5):614-21. PubMed ID: 19422582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era.
    Groeneveld PW; Matta MA; Suh JJ; Yang F; Shea JA
    Pacing Clin Electrophysiol; 2007 Apr; 30(4):463-71. PubMed ID: 17437568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Life in Young Adult Patients with a Cardiogenetic Condition Receiving an ICD for Primary Prevention of Sudden Cardiac Death.
    Verkerk AJ; Vermeer AM; Smets EM; Dekker LR; Wilde AA; Van Langen IM; Christiaans I; Nieuwkerk PT
    Pacing Clin Electrophysiol; 2015 Jul; 38(7):870-7. PubMed ID: 25880250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of implantable cardioverter-defibrillator recalls on patients' anxiety, depression, and quality of life.
    Undavia M; Goldstein NE; Cohen P; Sinthawanarong K; Singson M; Bhutani D; Munson T; Gomes JA; Fischer A; Mehta D
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1411-8. PubMed ID: 18950298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life of patients with implantable cardioverter defibrillators compared with that of pacemaker recipients.
    Leosdottir M; Sigurdsson E; Reimarsdottir G; Gottskalksson G; Torfason B; Vigfusdottir M; Eggertsson S; Arnar DO
    Europace; 2006 Mar; 8(3):168-74. PubMed ID: 16627433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of technology dependency on device acceptance and quality of life in persons with implantable cardioverter defibrillators.
    Udlis KA
    J Cardiovasc Nurs; 2013; 28(6):E65-73. PubMed ID: 23348222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term efficacy of a telephone intervention by expert nurses after an implantable cardioverter defibrillator.
    Dougherty CM; Lewis FM; Thompson EA; Baer JD; Kim W
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1594-602. PubMed ID: 15613121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
    Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of patient and partner quality of life and health outcomes in the first year after an implantable cardioverter defibrillator (ICD).
    Dougherty CM; Fairbanks AM; Eaton LH; Morrison ML; Kim MS; Thompson EA
    J Behav Med; 2016 Feb; 39(1):94-106. PubMed ID: 26345262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease.
    Ingles J; Sarina T; Kasparian N; Semsarian C
    Int J Cardiol; 2013 Oct; 168(4):3779-84. PubMed ID: 23835269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of early comprehensive cardiac rehabilitation following the implantation of cardioverter-defibrillator.
    Śmiałek J; Lelakowski J; Majewski J
    Kardiol Pol; 2013; 71(10):1021-8. PubMed ID: 24197582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concerns about implantable cardioverter-defibrillator shocks mediate the relationship between actual shocks and psychological distress.
    Thylén I; Moser DK; Strömberg A; Dekker RA; Chung ML
    Europace; 2016 Jun; 18(6):828-35. PubMed ID: 26324839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.